M.V.H Injection (Vial)

Adult administration

Adults: 1 ampoule (1 vial) of 5 mL is mixed directly in 500–1,000 mL of intravenously administered dextrose solution, normal saline, blood substitutes, or protein amino acid preparation solution and administered by slow intravenous drip.

This drug should not be administered more than 5,000 IU of vitamin A per day to women in the first three months of pregnancy or those who may become pregnant. This is because vitamin A carries the risk of inducing congenital malformations. When using an ampoule injection, care must be taken while cutting as glass fragments may be present, especially in children or the elderly. Patients allergic to any ingredients in this drug or those with hemophilia should not be administered this drug, as there is a risk of prolonged bleeding times for hemophilia patients. Patients with hypercalcemia or decreased kidney function may experience worsened symptoms due to vitamin D contained in this drug; therefore, blood and urine tests should be conducted to check their condition before administration. In children, excessive vitamin D may occur, so the dosage must be carefully adjusted; patients with allergic constitution or a history of drug hypersensitivity should also be administered with caution. During administration, hypersensitivity symptoms such as hypotension, respiratory distress, rash, and itching may occur; if any abnormal symptoms arise, administration should be stopped immediately and appropriate treatment sought. Pyridoxine hydrochloride included in this drug may reduce the effectiveness of levodopa; therefore, caution should be taken if taken together. Pregnant or breastfeeding women must follow a doctor's orders for administration due to the risk of adverse effects from excessive vitamin A intake, maintaining total intake of vitamin A below 5,000 IU per day. The elderly may have diminished physical function, so dosage adjustments and caution are necessary. This drug should be used immediately after opening, and any remaining drug should not be reused but discarded. Furthermore, the prescribed administration method and dosage should be strictly followed, and the infusion rate should be slow to prevent side effects such as venous pain. Store in a place not accessible to children, keep refrigerated, and avoid freezing. Pharmaceuticals should be stored in their original containers to prevent degradation or misuse.

Serious side effects

• Shock
• anaphylactic symptoms
• hypotension
• consciousness disorder
• respiratory distress
• cyanosis
• chest tightness
• difficulty breathing
• hives
• severe swelling (edema)

Mild side effects

• Nausea
• vomiting
• abdominal pain
• diarrhea
• rash
• itching
• warmth sensation
• chills
• fever
• perianal itching

To maintain freshness and effectiveness, this drug should be stored in a sealed container in the refrigerator at a temperature between 2 and 8 degrees Celsius. This storage method prevents deterioration or loss of efficacy of the drug.

Appearance

A brown vial injection containing a yellowish-brown liquid

Package unit

1 vial (5 mL) × 10